Trial Profile
A prospective, real life, observational study assessing efficacy and safety of long term tenofovir in high risk patients with hematological malignancies to prevent Hepatitis B Virus reactivation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary) ; Lamivudine
- Indications Haematological malignancies; Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 27 Dec 2015 New trial record